Neurological complications caused by SARS-CoV-2
Clinical Microbiology Reviews · 10.12.2024 · 37 (4)
DOI: 10.1128/cmr.00131-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 10.12.2024. Verfasst von Zehan Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases, SARS-CoV-2. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities).
Abstract (Originalsprache)
SARS-CoV-2 can not only cause respiratory symptoms but also lead to neurological complications. Research has shown that more than 30% of SARS-CoV-2 patients present neurologic symptoms during COVID-19 (A. Pezzini and A. Padovani, Nat Rev Neurol 16:636–644, 2020, https://doi.org/10.1038/s41582-020-0398-3 ). Increasing evidence suggests that SARS-CoV-2 can invade both the central nervous system (CNS) (M.S. Xydakis, M.W. Albers, E.H. Holbrook, et al. Lancet Neurol 20: 753–761, 2021 https://doi.org/10.1016/S1474-4422(21)00182-4 ) and the peripheral nervous system (PNS) (M.N. Soares, M. Eggelbusch, E. Naddaf, et al. J Cachexia Sarcopenia Muscle 13:11–22, 2022, https://doi.org/10.1002/jcsm.12896 ), resulting in a variety of neurological disorders. This review summarized the CNS complications caused by SARS-CoV-2 infection, including encephalopathy, neurodegenerative diseases, and delirium. Additionally, some PNS disorders such as skeletal muscle damage and inflammation, anosmia, smell or taste impairment, myasthenia gravis, Guillain-Barré syndrome, ICU-acquired weakness, and post-acute sequelae of COVID-19 were described. Furthermore, the mechanisms underlying SARS-CoV-2-induced neurological disorders were also discussed, including entering the brain through retrograde neuronal or hematogenous routes, disrupting the normal function of the CNS through cytokine storms, inducing cerebral ischemia or hypoxia, thus leading to neurological complications. Moreover, an overview of long-COVID-19 symptoms is provided, along with some recommendations for care and therapeutic approaches of COVID-19 patients experiencing neurological complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
- Department of Neurology, Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
- School of Life Sciences, Tianjin University, Tianjin, China.
ORCID-Profile: Zehan Pang, Ao Tang, Yujie He, Junfen Fan, Qingmao Yang, Yigang Tong, Huahao Fan
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)
- Nutrition and Care of Maternal & Child Research Project of Biotime Institute of Nutrition & Care
Zitieren
APA
Pang, Z., Tang, A., He, Y., Fan, J., Yang, Q., Tong, Y., & Fan, H. (2024). Neurological complications caused by SARS-CoV-2. Clinical Microbiology Reviews, 37(4). https://doi.org/10.1128/cmr.00131-24
Vancouver
Pang Z, Tang A, He Y, Fan J, Yang Q, Tong Y, et al. Neurological complications caused by SARS-CoV-2. Clinical Microbiology Reviews. 2024;37(4). doi:10.1128/cmr.00131-24
BibTeX
@article{Pang2024,
author = {Pang, Zehan and Tang, Ao and He, Yujie and Fan, Junfen and Yang, Qingmao and Tong, Yigang and Fan, Huahao},
title = {Neurological complications caused by SARS-CoV-2},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {4},
doi = {10.1128/cmr.00131-24}
}
EUVIMED